A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
Clinical trial NCT05699239 · COMPLETED
Trial details
- NCT number
- NCT05699239
- Sponsor
- Taisho Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-08
- Primary completion
- 2023-12-26
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.